Associate Director/Lead International HTA Strategy - Eye Care, Neuroscience & Specialty (all ge[...]

AbbVie; Paris; Sur place; EUR 80 000 - 100 000; Plein temps

Description du poste

Overview

AbbVie\'s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people\'s lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio.

Advances in scientific and technological research are opening new, promising treatments for previously difficult to treat diseases, increasing the demand on already constrained healthcare budgets. The challenging economic and political environment is leading Health Technology Assessment (HTA) agencies and payers to demand better outcomes at lower cost to the overall health system. The EU HTA regulation aims to accelerate patient access to innovative treatments by harmonizing methodologies, establishing predictability and avoiding duplications. For AbbVie, this provides a unique opportunity to demonstrate the value attributes of our assets and strengthen affiliate position in country Pricing & Reimbursement (P&R) appraisals. Joint Clinical Assessment (JCA) is a key component of the EU HTA regulation and comprises the EU HTA dossier that will be submitted to the Member State Coordination Group on HTA. For AbbVie, JCA enables better planning of market access strategies across Europe, driving the perception of value, removing redundancies with repetitive dossiers, saving time and ultimately resulting in smoother P&R negotiations to achieve faster and broader access for patients.

To succeed, we need to fully understand market value drivers, identify the evidence required for Pricing, Reimbursement and Access (PRA), and work with evidence generating functions to ensure that evidence generated will support successful JCA and HTA outcomes along with PRA negotiations.